Sivik Global Healthcare’s Thermo Fisher Scientific TMO Stock Holding History

Sivik Global Healthcare’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.93M	Hold	8,000	–	–	2.99%	12
2026 Q1	$3.93M	Sell	8,000 -4,000	-33%	-$2.17M	2.99%	12
2025 Q4	$6.95M	Sell	12,000 -2,000	-14%	-$1.13M	2.02%	14
2025 Q3	$6.79M	Buy	+14,000	New	+$6.52M	1.98%	16
2024 Q3	–	Sell	-14,000	Closed	-$7.74M	–	46
2024 Q2	$7.74M	Sell	14,000 -1,500	-10%	-$859K	2.78%	11
2024 Q1	$9.01M	Buy	15,500 +3,500	+29%	+$1.96M	2.11%	6
2023 Q4	$6.37M	Buy	12,000 +1,500	+14%	+$726K	2.66%	16
2023 Q3	$5.32M	Buy	10,500 +3,000	+40%	+$1.6M	2.69%	19
2023 Q2	$3.91M	Sell	7,500 -3,500	-32%	-$1.89M	0.92%	33
2023 Q1	$6.34M	Hold	11,000	–	–	2.73%	16
2022 Q4	$6.06M	Sell	11,000 -4,000	-27%	-$2.12M	2.85%	15
2022 Q3	$7.61M	Buy	15,000 +2,500	+20%	+$1.4M	4.23%	2
2022 Q2	$6.79M	Hold	12,500	–	–	3.86%	7
2022 Q1	$7.38M	Hold	12,500	–	–	3.05%	7
2021 Q4	$8.34M	Sell	12,500 -2,500	-17%	-$1.56M	3.57%	4
2021 Q3	$5.36M	Buy	+15,000	New	+$8.23M	1.28%	31
2021 Q2	–	Sell	-17,500	Closed	-$7.99M	–	60
2021 Q1	$7.99M	Buy	17,500 +2,500	+17%	+$1.19M	2.91%	13
2020 Q4	$6.99M	Sell	15,000 -5,000	-25%	-$2.34M	2.85%	17
2020 Q3	$8.83M	Sell	20,000 -86,069	-81%	-$35.6M	3.8%	4
2020 Q2	$4.04M	Buy	106,069 +6,069	+6%	+$2.03M	1.34%	33
2020 Q1	$3.59M	Buy	100,000 +82,500	+471%	+$26M	1.42%	32
2019 Q4	$5.68M	Buy	17,500 +2,500	+17%	+$758K	2.11%	24
2019 Q3	$4.37M	Hold	15,000	–	–	2.2%	25
2019 Q2	$4.41M	Sell	15,000 -5,000	-25%	-$1.38M	1.07%	25
2019 Q1	$5.47M	Buy	20,000 +5,000	+33%	+$1.24M	2.02%	23
2018 Q4	$3.36M	Sell	15,000 -5,000	-25%	-$1.17M	1.81%	28
2018 Q3	$4.88M	Sell	20,000 -10,000	-33%	-$2.3M	1.74%	27
2018 Q2	$6.21M	Buy	30,000 +10,000	+50%	+$2.12M	2.39%	14
2018 Q1	$4.13M	Buy	+20,000	New	+$4.2M	1.93%	21
2017 Q4	–	Sell	-45,000	Closed	-$8.51M	–	82
2017 Q3	$8.51M	Buy	45,000 +20,000	+80%	+$3.62M	2.9%	4
2017 Q2	$4.36M	Hold	25,000	–	–	1.6%	27
2017 Q1	$3.84M	Buy	25,000 +5,000	+25%	+$764K	1.79%	30
2016 Q4	$2.82M	Sell	20,000 -10,000	-33%	-$1.47M	1.35%	30
2016 Q3	$4.77M	Hold	30,000	–	–	2.41%	20
2016 Q2	$4.43M	Hold	30,000	–	–	2.2%	17
2016 Q1	$4.25M	Sell	30,000 -5,000	-14%	-$670K	1.88%	22
2015 Q4	$4.96M	Buy	+35,000	New	+$4.67M	2.36%	13
2014 Q2	–	Sell	-15,000	Closed	-$1.8M	–	79
2014 Q1	$1.8M	Sell	15,000 -15,000	-50%	-$1.78M	1.13%	46
2013 Q4	$3.34M	Buy	+30,000	New	+$2.98M	2.37%	13

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sivik Global Healthcare's TMO Position: Q2 2026 in Review

Sivik Global Healthcare held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 8,000 shares worth $3.93M. The position accounts for 2.99% of the portfolio, ranked #12.

Sivik Global Healthcare first reported a position in TMO in Q4 2013 and has held it in 39 quarters since. The position peaked at $9.01M in Q1 2024. 953 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Sivik Global Healthcare held 8,000 shares of Thermo Fisher Scientific worth $3.93M as of Q2 2026.
Sivik Global Healthcare left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 2.99% of Sivik Global Healthcare's portfolio in Q2 2026, its #12 holding.
Sivik Global Healthcare first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 39 quarters since.
Sivik Global Healthcare's Thermo Fisher Scientific position peaked at $9.01M in Q1 2024.
953 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.